158 related articles for article (PubMed ID: 33299501)
21. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
Han Z; Jia J; Lv Y; Wang R; Cao K
Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
[TBL] [Abstract][Full Text] [Related]
22. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
23. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
25. Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma.
Dono A; Zhu P; Holmes E; Takayasu T; Zhu JJ; Blanco AI; Hsu S; Bhattacharjee MB; Ballester LY; Kim DH; Esquenazi Y; Tandon N
J Neurooncol; 2022 Jan; 156(2):353-363. PubMed ID: 34997451
[TBL] [Abstract][Full Text] [Related]
26. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
27. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
[TBL] [Abstract][Full Text] [Related]
28. Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.
Yuan F; Yi L; Hai L; Wang Y; Yang Y; Li T; Tong L; Ma H; Liu P; Ming H; Ren B; Yu S; Lin Y; Yang X
Dis Markers; 2019; 2019():7049294. PubMed ID: 31772693
[TBL] [Abstract][Full Text] [Related]
29. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
[TBL] [Abstract][Full Text] [Related]
30. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
31. DGCR5 suppresses the EMT of pediatric primary glioblastoma multiforme cell and serves as a prognostic biomarker.
Yang F; Huang YL
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10024-10034. PubMed ID: 31799672
[TBL] [Abstract][Full Text] [Related]
32. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
33. Differentially expressed LncRNAs as potential prognostic biomarkers for glioblastoma.
Shao M; Liu W; Wang Y
Cancer Genet; 2018 Oct; 226-227():23-29. PubMed ID: 30005851
[TBL] [Abstract][Full Text] [Related]
34. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
[TBL] [Abstract][Full Text] [Related]
35. Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients.
Xiao H; Ding N; Liao H; Yao Z; Cheng X; Zhang J; Zhao M
Medicine (Baltimore); 2019 Nov; 98(45):e17583. PubMed ID: 31702614
[TBL] [Abstract][Full Text] [Related]
36. PLEKHG5 is a novel prognostic biomarker in glioma patients.
Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
38. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
Front Immunol; 2021; 12():706936. PubMed ID: 34899682
[TBL] [Abstract][Full Text] [Related]
39. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
40. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival.
Jing SY; Lu YY; Yang JK; Deng WY; Zhou Q; Jiao BH
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3992-3996. PubMed ID: 27775801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
